Rockefeller Capital Management
RCEL icon

Rockefeller Capital Management’s Avita Medical RCEL Stock Holding History

Rockefeller Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-220
Closed -$759 – 4847
2025
Q4 		$759 Buy
+220
New +$878 ﹤0.01% 4487

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rockefeller Capital Management's RCEL Position: Q1 2026 in Review

Rockefeller Capital Management sold out of Avita Medical (RCEL) in Q1 2026, closing a stake of 220 shares — an estimated $759 sold.

Rockefeller Capital Management first reported a position in RCEL in Q4 2025 and held it in 1 quarter. The position peaked at $759 in Q4 2025. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • Rockefeller Capital Management reported no remaining Avita Medical position as of Q1 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 220 Avita Medical shares in Q1 2026, an estimated $759.
  • Rockefeller Capital Management first reported a position in Avita Medical in Q4 2025 and held it in 1 quarter.
  • Rockefeller Capital Management's Avita Medical position peaked at $759 in Q4 2025.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.